
Pharma brands with all the right information are still invisible to AI — and why silence is the bigger risk than inaccuracy.
DeepIntent, a healthcare advertising technology company built to influence better patient health and business outcomes, announced it has reached a significant milestone, achieving growth for the fifth consecutive year and a triple-digit percentage growth rate across connected television (CTV) campaigns.
In 2022, DeepIntent experienced triple-digit growth in CTV investment on its demand side platform, making CTV one of the fastest-growing channels for the hundreds of pharmaceutical brands now using the DeepIntent Healthcare Advertising Platform.